Shell Asset Management CO Cara Therapeutics, Inc. Transaction History

Shell Asset Management CO

  • $2.29 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021
SELL
$15.07 - $21.71 $410,989 - $592,075
-27,272 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$12.72 - $16.16 $49,569 - $62,975
-3,897 Reduced 12.5%
27,272 $413,000
Q3 2020

Nov 13, 2020
BUY
$12.34 - $17.92 $384,625 - $558,548
31,169 New
31,169 $397,000

Others Institutions Holding CARA

# of Institutions
10
Shares Held
826K
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $857M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email